MAT and Suboxone® for Opioid Recovery.

Medication-Assisted Treatment with Suboxone® (buprenorphine and naloxone), Sublocade® or Brixadi® (long-acting forms of injectable buprenorphine), paired with counseling and steady follow-up. The combination is what makes MAT actually work.

Treatment, explained simply.

What Suboxone does

Quiets cravings and withdrawal

Buprenorphine is a partial opioid agonist that binds to opioid receptors without the high. The naloxone in Suboxone discourages misuse. Together they make stability possible.

Medication plus counseling

Both halves, every time

MAT works best when medication and counseling run side by side. We pair every buprenorphine patient with a therapist or peer support, depending on what fits.

Long-term recovery

Care that scales with you

Recovery isn't a sprint. We support patients on buprenorphine for as long as it helps. Tapering, when it happens, is slow, planned, and patient-led.

From consultation to lasting relief.

  1. Intake and screening

    60 minute first visit

    We confirm the diagnosis, review your history, run any needed labs, and check for medication interactions. We'll explain buprenorphine fully so you know exactly what to expect.

  2. Induction

    First 1 to 3 days

    You start buprenorphine once you begin to feel withdrawal symptoms. We coach you through the first dose, often by phone or video, and check in within 24 hours.

  3. Stabilization

    First 4 to 8 weeks

    Weekly visits while we find your effective dose. Cravings ease. Sleep, appetite, and energy return. We coordinate with your therapist and primary care.

  4. Maintenance

    Visits every 4 to 12 weeks

    Once stable, follow-ups stretch out. Many patients stay on buprenorphine long-term. If and when tapering makes sense, we plan it slowly and check in often.

You may be an ideal candidate if any of these ring true.

  • You're using prescription opioids or heroin and want to stop without going through full unmedicated withdrawal.
  • You've tried abstinence-based programs and they haven't held.
  • You want a confidential, judgment-free clinic where the prescriber actually understands addiction medicine.
  • You need a provider who accepts Medicaid or your commercial plan.
  • You're already on Suboxone but your current prescriber isn't a good fit.

Frequently Asked Questions

No. Buprenorphine is a medication, used at a steady prescribed dose to treat a medical condition. Decades of evidence show MAT cuts overdose deaths and helps people rebuild their lives. Recovery on Suboxone is recovery.
As long as it helps. Many patients stay on it for years. Some taper after a stable period. There's no fixed expiration date, and we don't push tapering until you're ready.
No. For people with opioid use disorder, buprenorphine doesn't produce a meaningful high. It quiets cravings and withdrawal so you can function and rebuild.
Yes. Some patients are candidates for long-acting injectable buprenorphine, including Sublocade and Brixadi. These medications are given in the office and slowly release buprenorphine over time. They can be helpful for patients who want fewer daily reminders of treatment, have trouble remembering doses, or want more structure and privacy.
Sublocade and Brixadi are long-acting injectable forms of buprenorphine. Instead of taking medication every day, the medication is given as an injection that slowly releases over time. Sublocade is given monthly. Brixadi has weekly and monthly options. For the right patient, injections can reduce missed doses, lower diversion risk, and make treatment feel less like a daily burden. They are still MAT. They are still recovery.
Often, yes. Many patients start with Suboxone or another oral buprenorphine medication first, then switch to a long-acting injection once they are stable. This can be a good option if daily dosing is inconvenient, triggering, easy to forget, or hard to manage safely. It is not the right fit for everyone, and insurance rules vary. We will review your history, dose, goals, and coverage before recommending Sublocade, Brixadi, or staying with Suboxone.
We strongly recommend it, and we pair patients with a therapist as part of MAT. Medication alone helps. Medication plus counseling helps more.
Most commercial plans, Medicare, and the Medicaid programs we participate in cover Suboxone and MAT visits. Our care team verifies your benefits up front.
In many cases yes, after an initial in-person or video visit, depending on state rules. Federal flexibilities have made buprenorphine telehealth more accessible. We'll explain what applies to your state.
Buprenorphine is one of the standard treatments for opioid use disorder during pregnancy. We coordinate closely with OB-GYN to keep both you and the baby safe.

Covered by most major plans, including Virginia Medicaid.

Our care coordinators verify benefits, submit prior authorizations, and coordinate every approval before you begin. Most consultations happen within 3 to 5 business days.

  • Anthem
  • Aetna
  • Cigna
  • BCBS
  • Medicare
  • Medicaid

Don't see your plan? Call (800) 983-1974. We work with most insurers and can verify coverage in a single call.

Trademark Notice: SUBOXONE® and SUBLOCADE® are registered trademarks of Indivior UK Limited or its affiliates. BRIXADI® is a trademark of Braeburn Inc. Foundation Medical Group is not affiliated with, sponsored by, endorsed by, or otherwise connected with Indivior, Braeburn, or their affiliates. References to these medications are for informational purposes only and do not imply any manufacturer endorsement, partnership, or special relationship. Medication decisions are made by licensed clinicians after an individual evaluation.

Ready to take
the first step?

Call, book online, or walk in. We'll take it from there.

Same-day appointments All major insurance